Abstract
Fibromyalgia (FMS) is a chronic, painful disorder often associated with measurable deficiencies in attention. Since EEG biofeedback (EEG-BF) has been used successfully to treat attention problems, we reasoned that this modality might be helpful in the treatment of attention problems in FMS. We also speculated that improvement in central nervous system (CNS) function might be accompanied by improvement in FMS somatic symptoms. We studied fifteen FMS patients with attention problems, demonstrated by visual and auditory continuous performance testing (CPT), while completing 40 or more EEG-BF sessions. Training consisted of a “SMR protocol” that augmented 12–15 Hz brainwaves (sensory motor rhythm; SMR), while simultaneously inhibiting 4–7 Hz brainwaves (theta) and 22–30 Hz brainwaves (high beta). Serial measurements of pain, fatigue, psychological distress, morning stiffness, and tenderness were also obtained. Sixty-three FMS patients who received standard medical care, but who did not receive EEG-BF, served as controls. Visual, but not auditory, attention improved significantly (P < 0.008). EEG-BF treated subjects also showed improvement in tenderness, pain and fatigue. Somatic symptoms did not change significantly in controls. Visual attention parameters and certain somatic features of FMS appear to improve with an EEG-BF SMR protocol. EEG-BF training in FMS deserves further study.
Similar content being viewed by others
References
Aaron, L. A., Bradley, L. A., Alarcon, G. S., Alexander, R. W., Triana-Alexander, M., Martin, M. Y., & Alberts, K. R. (1996). Arthritis Rheum, 39, 436–445.
Ader, R. (Ed.). (2007). Psychoneuroimmunology, New York. Academic Press.
Aickin, M., & Gensler, H. (1996). Adjusting for multiple testing when reporting research results: The Bonferroni versus Holm methods. American Journal of Public Health, 86, 726–728.
Bedwell, J. S., Kamath, V., & Compton, M. T. (2009). The relationship between interview-based schizotypical personality dimension scores and the continuous performance test. Schizophrenia Research, 108, 158–162.
Bove, E. A. (2008). Cognitive performance and basic symptoms in first-degree relatives of schizophrenic patients. Comprehensive Psychiatry, 49, 321–329.
Caro, X. J. (1989). Is there an immunologic component to the fibrositis syndrome? Rheumatic Diseases Clinics of North America, 15, 169–186.
Caro, X. J., & Winter, E. F. (2005). Nerve conduction tests in patients with fibromyalgia syndrome. Rheumatology International, 25(1), 77–78.
Caro, X. J., & Winter, E. F. (2008). Evidence of abnormal epidermal nerve fiber density in fibromyalgia. Arth Rheum, 59(9), S388.
Caro, X. J., Winter, E. F., & Dumas, A. (2008). A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy (CIDP) and appear to respond to IVIg. Rheumatology (Oxford), 47, 208–211.
Chen, P. S., Yang, Y. K., Su, S.-F., Liao, Y.-C., Chang, J.-W., & Yeh, A. T. L. (2004). Correlation between scores on continuous performance test and plasma concentration for schizophrenic patients on risperidone. Psychiatry Clinical Neuroscience, 58, 168–172.
Christensen, H., Griffiths, K., MacKinnon, A., & Jacomb, P. (1997). A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. Journal of International Neuropsychological Society, 3, 631–651.
Cohen, H., Neuman, L., Kotler, M., & Buskila, D. (2001). Autonomic nervous system derangement in fibromyalgia syndrome and related disorders. The Israel Medical Journal, 10, 755–760.
Corkum, P. V., & Siegel, L. S. (1993). Is the continuous performance task a valuable research tool for use with children with attention-deficit-hyperactivity disorder? Journal of Child Psychology and Psychiatry, 34, 1217–1239.
Côté, K. A., & Moldofsky, H. (1997). Sleep, daytime symptoms, and cognitive performance in patients with fibromyalgia. Journal of Rheumatology, 24, 2014–2022.
Cott, A., Parkinson, W., Bell, M. J., Adachi, J., & Bedard, M. (1992). Inter-rater reliability of the tender point criterion for fibromyalgia. Journal of Rheumatology, 19, 1955–1959.
Crofford, L. J. (1998). Neuroendocrine abnormalities in fibromyalgia and related disorders. American Journal of the Medical Sciences, 315, 359–366.
Demitrak, M. A., & Crofford, L. J. (1998). Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Annals of the New York Academy of Sciences, 840, 684–697.
Dick, B., Eccleston, C., & Crombez, G. (2002). Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients. Arthritis and Rheumatism, 47, 639–644.
Epstein, J. N., Erkanli, A., Conners, C. K., Klaric, J., Costello, J. E., & Angold, A. (2003). Relations between continuous performance test performance measures and ADHD behaviors. Journal of Abnormal Child Psychology, 31, 543–554.
Evans, J. R., & Abarbanel, A. (1999). Introduction to quantitative EEG and Neurofeedback. Academic Press: San Diego.
Glass, J. M., & Park, D. C. (2001). Cognitive dysfunction in fibromyalgia. Current Rheumatology Reports, 3, 123–127.
Glesecke, T., Williams, D. A., Harris, R. E., Cupps, T. R., Tian, T. X., Gracely, R. H., Clauw, D. J. (2003). Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis and Rheumatism, 48, 2916–2922.
Grace, G. M., Nielson, W. R., Hopkins, M., & Berg, M. A. (1999). Concentration and memory deficits in patients with fibromyalgia syndrome. Journal of Clinical Experimental Neuropsychology, 21, 477–487.
Gracely, R. H., Petzke, F., Wolf, J. M., & Clauw, D. J. (2002). Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism, 46, 1333–1343.
Greenberg, L. M., & Kindschi, C. L. (1996). T.O.V.A Clinical guide (20). Los Alamitos, CA: Universal Attention Disorders Inc.
Griep, E. N., Boersma, J. W., Lentjes, E. G., Prins, A. P., van der Korst, J. K., & de Kloet, E. R. (1998). Function of the hypothalmic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. Journal of Rheumatology, 25, 1374–1381.
Grizenko, N., Lachance, M., Collard, V., Lageix, P., Baron, C., Amor, L., et al. (2004). Sensitivity of tests to assess improvement in ADHD symptomatology. Canadian Child and Adolescent Psychiatry Review, 13(2), 36–39.
Jasper, H. H. (1958). The 10–20 electrode system of the international federation. EEG Clinical Neurophysiology, 10, 371–375.
Johansson, G., Risberg, J., Rosenhall, U., Örndahl, G., Svennerholm, L., & Nyström, S. (1995). Cerebral dysfunction in fibromyalgia: evidence from regional cerebral blood flow measurements, otoneurological tests and cerebrospinal fluid analysis. Acta Psychiatrica Scandinavica, 91, 86–94.
Kayiran, S., Dursun, E., Ermutlu, N., & Karamürsel, S. (2007). Neurofeedback in fibromyalgia syndrome. Agriculture, 19(3), 47–53.
Kwiatek, R., Barnden, L., Tedman, R., Jarrett, R., Chew, J., Rowe, C., et al. (2000). Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis and Rheumatism, 43, 2823–2833.
Landro, N. I., Stiles, T. C., & Sletvold, H. (1997). Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. Journal of Psychosomatic Research, 42, 297–306.
Leark, R. A., Dupuy, T. R., Greenberg, L. M., et al. (1999). TOVA (Test of Variables of Attention): Professional guide. Los Alamitos, CA: Universal Attention Disorders, Inc.
Lee, Y. C., Nasskikas, N. J., & Clauw, D. J. (2011). The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis, and fibromyalgia. Arthritis Research Therapy, 13, 211.
Lubar, J. F. (1995). Neurofeedback for the Management of Attention-Deficit/Hyperactivity Disorder. In M. S. Schwartz, et al. (Eds.), Biofeedback, a practitioner’s guide (2nd ed., pp. 493–522). New York: The Guilford Press.
McDermid, A. J., Rollman, G. B., & McCain, G. A. (1996). Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain, 66, 133–144.
Monastra, V. J. (2008). Quantitative electroencephalography and attention-deficit/hyperactivity disorder: Implications for clinical practice. Current Psychiatric Reports, 10, 432–438.
Monastra, V. J., Lynn, S., Linden, M., Lubar, J. F., Gruzelier, J., & LaVaque, T. J. (2005). Electroencephalographic biofeedback in the treatment of attention-deficit/hyperactivity disorder. Applied Psychophysiology Biofeedback, 30(2), 95–114.
Mountz, J. M., Bradley, L. A., Modell, J. G., Alexander, R. W., Triana-Alexander, M., Aaron, L. A., et al. (1995). Fibromyalgia in women: abnormalities of regional blood flow in the thalamus and caudate nucleus are associated with low pain threshold levels. Arthritis and Rheumatism, 138, 926–938.
Mountz, J. M., Bradley, L. A., & Alarcón, G. S. (1998). Abnormal functional activity of the central nervous system in fibromyalgia syndrome. American Journal of the Medical Sciences, 315, 385–396.
Mueller, H. H., Donaldson, C. C., Nelson, D. V., & Layman, M. (2001). Treatment of fibromyalgia incorporating EEG-driven stimulation: a clinical outcomes study. Journal of Clinical Psychology, 57(7), 933–952.
Mussgay, L., & Hertwig, D. M. (1990). Signal detection indices in schizophrenia on a visual, auditory, and bimodal continuous performance test. Research, 3, 303–310.
Olsen, N. J., & Park, J. H. (1998). Skeletal muscle abnormalities in patients with fibromyalgia. American Journal of the Medical Sciences, 315, 351–358.
Park, J. H., Nierman, K. J., & Olsen, N. (2000). Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Current Rheumatology Reports, 2, 131–140.
Park, D. C., Glass, J. M., Minear, M., & Crofford, L. J. (2001). Cognitive function in fibromyalgia patients. Arthritis and Rheumatism, 44, 2125–2133.
Pickering, G., Jourdan, D., Eschalier, A., & Dubray, C. (2002). Impact of age, gender and cognitive functioning on pain perception. Gerontology, 48(2), 112–118.
Raj, S. R., Brouillard, D., Simpson, C. S., Hopman, W. M., & Abdollah, H. (2000). Dysautonomia among patients with fibromyalgia: A noninvasive assessment. Journal of Rheumatology, 27(11), 2660–2665.
Reyero, F., Ponce, G., Rodriguez-Jimenez, R., Fernandez-Dapica, P., Taboada, D., Martin, V., Navio M., Jimenez-Arriero, M. A., & Hoenicka, J., Palomo, T. (2010). High frequency of childhood ADHD history in women with fibromyalgia. European Psychiatry (Epub ahead of print).
Riccio, C. A., Waldrop, J. J. M., Reynolds, C. R., & Lowe, P. (2001). Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation. Journal of Neuropsychiatry Clinical Neuroscience (Summer) 13, 326–335.
Salemi, S., Rethage, J., Wollina, U., Michael, B. A., Gay, R. E., Gay, S., et al. (2003). Detection of interleukin 1 beta (IL-1beta), IL-6, and tumor necrosis factor—alpha in skin of patients with fibromyalgia. Journal of Rheumatology, 30(1), 146–150.
Solanto, M. V., Etefia, K., & Marks, D. J. (2004). The utility of self-report measures and the continuous performance test in the diagnosis of ADHD in adults. CNS Spectrometer, 9, 649–659.
Sprott, H., Salemi, S., Bradley, L. A., Alarcón, G. S., Oh, S. J., Michel, B. A., et al. (2004). Increased DNA fragmentation and ultrastructural changes in fibromyalgia muscle fibres. Annals of the Rheumatic Diseases, 63(3), 245–251.
Staud, R. (2010). Is it all central sensitization? Role of peripheral tissue nociception in chronic musculoskeletal pain. Current Rheumatology Reports, 12, 448–454.
Tunks, E., McCain, G. A., Hart, L. E., Teasell, R. W., Goldsmith, C. H., Rollman, G. B., et al. (1995). The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. Journal of Rheumatology, 22, 944–952.
Ulas, U. H., Unlu, E., Hamamcioglu, K., Odabasi, Z., Cakci, A., & Vural, O. (2006). Dysautonomia in fibromyalgia syndrome: sympathetic skin responses and RR interval analysis. Rheumatology International, 26(5), 383–387.
Wilke, W. S. (2009). New developments in the diagnosis of fibromyalgia syndrome: Say goodbye to tender points? Cleveland Clinical Journal of Medicine, 76, 345–352.
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis and Rheumatism, 33, 160–172.
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., et al. (1997a). A prospective longitudinal multicenter study of service utilization and costs in fibromyalgia. Arthritis and Rheumatism, 40, 1560–1570.
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., et al. (1997b). Health status and disease severity in fibromyalgia. Arthritis and Rheumatism, 40, 1571–1579.
Yunus, M. B., Ahles, T. A., Aldaq, J. C., & Masi, A. T. (1991). Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis and Rheumatism, 34, 15–21.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caro, X.J., Winter, E.F. EEG Biofeedback Treatment Improves Certain Attention and Somatic Symptoms in Fibromyalgia: A Pilot Study. Appl Psychophysiol Biofeedback 36, 193–200 (2011). https://doi.org/10.1007/s10484-011-9159-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10484-011-9159-9